scispace - formally typeset
Z

Zafer Kocak

Researcher at Trakya University

Publications -  91
Citations -  1272

Zafer Kocak is an academic researcher from Trakya University. The author has contributed to research in topics: Lung cancer & Carcinoma. The author has an hindex of 20, co-authored 85 publications receiving 1149 citations. Previous affiliations of Zafer Kocak include Duke University.

Papers
More filters
Journal ArticleDOI

Challenges in defining radiation pneumonitis in patients with lung cancer

TL;DR: Scoring of radiation pneumonitis was challenging in 28% of patients treated for lung cancer owing to confounding medical conditions, and recognition of this uncertainty is needed and may limit the ability to understand RT-induced lung injury.
Journal ArticleDOI

High Plasma d-dimer Level is Associated with Decreased Survival in Patients with Lung Cancer

TL;DR: Elevated plasma levels of D-dimer in patients with lung cancer are associated with decreased survival and a poor response to treatment, and pre-treatment for the D-Dimer level may be useful in the prediction of survival and the response totreatment.
Journal ArticleDOI

Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study.

TL;DR: The study was conducted with the aim of reviewing the clinical features, therapy, and natural course of patients with extrapulmonary small‐cell carcinoma (EPSCC) and SCLC to better define current concepts regarding EPSCCs.
Journal ArticleDOI

Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis.

TL;DR: The prospective model appears unable to accurately segregate patients into high vs. low risk groups of RT-induced lung injury, which is consistent with prior studies suggesting that dosimetric and functional parameters are predictive for RT- induced pneumonitis.
Journal ArticleDOI

Granulosa cell tumor of the ovary: retrospective analysis of 45 cases.

TL;DR: Despite the small number of patients, the study showed that stage and macroscopic residual disease are significant prognostic factors and the benefit of chemotherapy and radiotherapy remains controversial.